Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B
The solution will appear blue due to GHK-Cu copper chelation
This review integrates mechanistic insights with translational advances, outlining how dysregulation of chaperones, autophagy-mitophagy, the ubiquitinproteasome system, and ER stress pathways drive human diseases, while highlighting emerging therapeutic platforms, from pharmacological chaperones and autophagy modulators to targeted protein degradation technologies, CRISPR screens, spatial biology, and AI-guided drug discovery
Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, et al
Oxidative stress: a suitable therapeutic target for optic nerve diseases
This peptide, has a unique mechanism of action that targets sleep cycles